Aptamer Group signs agreement worth up to £155,000

Aptamer Group plc (LON: APTA) secures a £155,000 contract to develop Optimer® binders for a rare disease biopharma, boosting clinical trial capabilities...

Time Finance reports 44% profit increase as lending book grows

Time Finance plc reports a robust H1 2024/25 performance with a 16% revenue rise and a 44% increase in profit before tax, continuing its growth momentum...

Avation concludes share buyback

Avation PLC completes a strategic repurchase of 7.8 million shares, enhancing shareholder value and optimizing capital structure through buyback...

Zotefoams updates on ReZorce® circular packaging technology

Zotefoams plc updates on ReZorce® circular packaging, pausing investment while focusing on core foam businesses, aligning with market expectations...

Hardide signs 10-year aerospace supply agreement

Hardide plc secures a 10-year deal for coating aerospace cargo door components, boosting revenue prospects with its cutting-edge tungsten-carbide coatings...

Biome Technologies agrees secured funding loan facility

Biome Technologies plc (LON:BIOM) secures a £750,000 loan facility from Non-Executive Directors to provide essential working capital amid project delays...

Duke Capital declares interim dividend of 0.70 pence per share

Duke Capital Limited (LON: DUKE) announces a 0.70 pence interim dividend for Q3 2024, with payments set for January 2025...

Strix Group reports progress on debt, new technology and reinstating dividend amidst headwinds

Strix Group Plc (LON:KETL) reports a trading update for FY24, highlighting challenges and strategic growth in sustainable water technologies and appliances...

Ferro-Alloy Resources secures six-year vanadium offtake deal with LLR

Ferro-Alloy Resources Limited secures a non-binding offtake with LL-Resources for vanadium pentoxide from its Balasausqandiq Project in Kazakhstan...

Cizzle Biotechnology expands CIZ1B lung cancer test licensing to Caribbean

Cizzle Biotechnology expands its CIZ1B biomarker test agreement to the Caribbean, accelerating market entry for early lung cancer detection in 2025...

GSK Plc’s Nucala approved in China as a treatment for CRSwNP

GSK's Nucala has been approved in China as an add-on treatment for CRSwNP, marking the first anti-IL-5 therapy for adults with this chronic condition...

Rio Tinto Plc 2025 dividend schedule and key event dates

Discover Rio Tinto plc's (LON:RIO) key financial and corporate event dates for 2025, including dividend announcements and annual general meetings...

Tim Cobbold named Chair of Spirax Group, succeeding Jamie Pike

Tim Cobbold becomes Chair of Spirax Group, succeeding Jamie Pike. Cobbold will lead Board initiatives and engage with shareholders to drive growth...

Vodafone Group Plc completes sale of its Italian operations to Swisscom

Vodafone Group Plc completes the sale of Vodafone Italy to Swisscom AG for €8 billion, aiding debt reduction and shareholder returns...

Aviva acquires Direct Line in £3.7 billion cash and share deal

Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders...

AstraZeneca’s Tagrisso approved in the EU for patients with unresectable NSCLC

AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials...

CMC Markets Plc declares interim dividend of 3.10 pence per share

CMC Markets Plc declares a 3.10 pence interim dividend per share for H1 2024, payable on 9 January 2025, with a DRIP option available...

Edinburgh Investment Trust Plc H1 NAV outperforms FTSE All-Share Index

Edinburgh Investment Trust plc (LON:EDIN) outperforms, with NAV rising 8.3% and share price up 10.8%. Dividend increases as discount narrows...

Marshalls Plc hosting a Capital Markets Event today

Marshalls plc unveils its new strategic focus, "Transform and Grow," at its Capital Markets Event, targeting sustainable market outperformance...

Ruffer Investment Company reports on October market challenges and strategic adjustments

Ruffer Investment highlights October 2024 market challenges impacting bonds and equities. Explore their strategic adjustments amid global fiscal shifts...

Worldwide Healthcare Trust Plc outperforms benchmark in H1 results

Worldwide Healthcare Trust PLC (LON:WWH) outperformed its benchmark in the half-year results ending 30 September 2024, recording notable returns...

Syncona launches Slingshot to advance early-stage biotech innovations

Syncona Ltd launches Slingshot Therapeutics, investing £12.5 million to advance academic innovations into biotech with a focus on inflammatory diseases...

AIM All Share Index

Trending Articles

Search

Search

Currency